This bill provides temporary student loan relief for federal employees and their supporting contractors during government shutdowns. If a shutdown lasts 14+ days in 2026 or later, the Secretary of Education must suspend all federal student loan payments for these "covered individuals," halt interest accrual, and count the suspended months toward loan forgiveness eligibility. It also requires credit reporting agencies to treat suspended payments as if made on time and allows refunds for payments made during qualifying shutdowns. The relief applies retroactively from September 2025.
The American Energy Independence and Affordability Act extends multiple clean energy tax credits that were set to expire between 2025 and 2026. It specifically extends residential clean energy credits through 2034, clean electricity investment credits for wind and solar through 2032, and clean vehicle credits for electric vehicles through 2032. The bill also reinstates special rates for sustainable aviation fuel and modifies requirements for energy-efficient home improvements. These provisions directly affect homeowners installing solar panels, businesses investing in clean energy infrastructure, and manufacturers producing clean energy equipment.
HR 5855, the Measuring the Cost of Disasters Act of 2025, requires the National Oceanic and Atmospheric Administration (NOAA) to create and maintain a public database and webpage tracking U.S. billion-dollar disasters. The database must include each disaster’s estimated cost, type, location, date, and visual mapping features showing trends over time, updated at least twice yearly. It defines a "billion-dollar disaster" as events costing $1 billion or more in combined direct and economic costs, and mandates NOAA to use existing data sources while continuing to archive the previous NCEI disaster database. This bill directly affects the public and researchers by providing transparent, accessible data on disaster impacts, without altering disaster response or funding mechanisms.
HRES 833 is a non-binding resolution passed by the U.S. House of Representatives to honor Dr. Jane Goodall, a renowned primatologist, conservationist, and advocate for wildlife protection. The resolution recognizes her groundbreaking chimpanzee research at Gombe Stream, her founding of the Jane Goodall Institute and Roots and Shoots program (which engages youth in environmental action globally), and her decades-long advocacy for ethical animal treatment and conservation. It commemorates her legacy following her passing on October 1, 2025, and extends condolences to her family and affiliated organizations. This resolution has no legal effect but serves as a symbolic tribute to her global environmental impact.
This resolution expresses the U.S. House of Representatives' support for recognizing October 26, 2025, as Intersex Awareness Day, which honors intersex individuals - those with natural variations in physical sex characteristics (such as anatomy, hormones, or chromosomes) that differ from typical male or female bodies. It affirms the day’s goals of promoting bodily autonomy and addressing issues like nonconsensual medical procedures on intersex children. The resolution encourages federal agencies, schools, and organizations to observe the day through educational activities that increase public awareness and support for the intersex community. It does not create new laws or policies but symbolically aligns with existing federal actions promoting nondiscrimination and health equity for intersex people.
S.Res. 466 is a non-binding Senate resolution condemning President Trump's pardon of Binance founder Changpeng Zhao, who had pleaded guilty to violating U.S. anti-money laundering laws. The resolution highlights financial connections between the Trump family and Zhao's company, including the use of the Trump family's cryptocurrency in a $2 billion Binance transaction, and calls on Congress to take action against what it describes as corrupt pardons. As a symbolic measure, it does not create new law but formally expresses the Senate's disapproval of the pardon and urges legislative steps to prevent similar conflicts. The resolution was introduced on October 23, 2025, the same day Trump granted Zhao's pardon.
This bill provides back pay to federal employees, military personnel, and certain contractors who lost compensation due to a government funding lapse during the period from October 1, 2025, through the bill's enactment date. It appropriates funds from the Treasury to cover "standard employee compensation" (including base pay, allowances, and benefits) for all covered individuals during the shutdown period, requiring agencies to distribute payments within 7 days of enactment. The funds may only be used for this specific purpose and cannot be redirected to other agency needs. The pay is retroactive to September 30, 2025, treating affected individuals as if they had received full pay continuously during the shutdown.
The TREATS Act amends the Controlled Substances Act to allow telehealth evaluations as an alternative to in-person medical evaluations for prescribing certain controlled substances. Specifically, it permits one telehealth evaluation (conducted via real-time audio/video systems meeting Social Security Act standards) instead of an in-person visit when prescribing FDA-approved medications for substance use disorder treatment (schedules III-V). This directly affects healthcare providers who prescribe these medications, expanding their ability to use telehealth for initial patient assessments. The change maintains the requirement for at least one evaluation (either in-person or telehealth) while updating the process to include telehealth options for this specific treatment context.
This bill ensures federal employees, contractors, and military personnel affected by a government shutdown starting October 1, 2025, receive their regular pay and benefits during the shutdown period. It appropriates funds to cover standard pay, allowances, and benefits for "covered individuals" until appropriations are enacted (the "termination date"). The bill also prohibits agencies from implementing layoffs or placing employees on administrative leave for more than 10 workdays during the shutdown. It applies retroactively to September 30, 2025, and charges the costs to future appropriations.
This resolution extends authorities related to the enforcement of several budget points of order in the Senate through FY2027. Budget points of order are used to enforce congressional budget procedures and substantive provisions of a congressional budget resolution (e.g., spending allocations). If a Senator successfully raises a budget point of order against legislation, further consideration of the legislation is generally prohibited unless the Senate waives the budget point of order. A motion to waive most budget points of order in the Senate requires an affirmative vote of three-fifths of all Senators duly chosen and sworn (60 votes if there are no vacancies). This resolution extends provisions that require this three-fifths vote of the Senate to waive several specified budget points of order.
HRES 822 is a non-binding resolution designating October 23, 2025, as "National Marine Sanctuary Day." It supports raising public awareness about the National Marine Sanctuary System, which protects ocean and Great Lakes areas for conservation, recreation, and cultural heritage. The resolution encourages responsible visits to sanctuaries and recognizes their economic benefits, including supporting jobs in tourism and fishing. It does not create new laws or funding but formally acknowledges the system’s role in preserving marine ecosystems and coastal communities. This symbolic gesture aims to foster public engagement with marine sanctuaries across the U.S.
S 3019, the "No Big Blockbuster Bailouts Act," amends Medicare's drug price negotiation program to change how orphan drugs (treatments for rare diseases) are handled. It raises the revenue threshold from $200 million to $400 million before orphan drugs become subject to price negotiations under Medicare. This directly affects pharmaceutical companies developing drugs solely for rare diseases, as they will face price negotiations only if their annual U.S. revenue exceeds $400 million. The change applies to initial price negotiations starting January 1, 2028.
